Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Naval Medical Forces Pacific’s commander tours NH Twentynine Palms

Article
11/12/2020
Four military personnel in uniform, wearing masks

Weber was briefed on the implementation of MHS GENESIS...and the hospital's response to COVID-19.

Recommended Content:

Combat Support | Health Readiness | Coronavirus | MHS GENESIS

Forging of civil-military anvil against COVID-19 focus at GHSA

Article
11/9/2020
U.S. and Thai soldiers stand together during a medical exercise.

“Defense partnerships around the world are key.”

Recommended Content:

Coronavirus | Global Health Engagement | Health Readiness | Global Health Engagement

BAMC, Argentine Army medical providers share COVID-19 best practices

Article
11/4/2020
Video teleconference image

U.S. Army South facilitated the virtual subject matter expert (SME) exchange between BAMC and CMMH.

Recommended Content:

Coronavirus | Global Health Engagement | Technology | COVID-19 Vaccine Efforts | Public Health | Convalescent Plasma Collection Program

How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

Video
11/3/2020
How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

This video provides a detailed overview of the processes that have been implemented to accelerate the pace of the COVID-19 vaccine and antibody studies, and what is being done to assure safety.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

The Importance of Enrolling Diverse Participants in COVID-19 Studies

Video
11/3/2020
The Importance of Enrolling Diverse Participants in COVID-19 Studies

This video discusses why enrolling diverse participants in COVID-19 studies is critical for ensuring that, when we find a vaccine, we have enough data from populations who are most affected by COVID-19 to determine vaccine safety and efficacy.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus

NMCP unveils new COVID-19 testing system

Article
11/2/2020
A group of military health personnel, wearing masks, in front of a large machine with a red ribbon in front of it.

Each Panther system can provide initial results in approximately four hours.

Recommended Content:

Coronavirus

Military nurses hold virtual research & evidence-based practice course

Article
10/30/2020
Two nurses, wearing masks, examining a mannequin

Due to the COVID-19 national emergency, the three-day in-person course was abbreviated to a one-day virtual.

Recommended Content:

Coronavirus | Public Health | Combat Support | Research and Innovation

‘Virtual Ward’ pilot program to reduce hospital stay time

Article
10/30/2020
Man's arm with blood pressure cuff and fingertip pulse oximeter

"The idea is that instead of staying in hospital longer..., patients are released early and can recover in the comfort and privacy of their homes."

Recommended Content:

Health Readiness | Technology | Coronavirus | Public Health

COVID-19 amplifies importance of Trusted Care culture

Article
10/29/2020
Image of soldier holding up a badge that says "Trusted Care."

The goal is to create a team of innovators focused on patient safety.

Recommended Content:

Coronavirus

JBLM hosts vital blood drive during COVID-19

Article
10/29/2020
Soldier giving blood

To maintain social distancing requirements, all blood drives are by appointment only.

Recommended Content:

Armed Services Blood Program | Public Health | Coronavirus

WRNMMC expands innovation and opens new, permanent drive-thru pharmacy

Article
10/23/2020
Military pharmacist, wearing a mask, looking at bags of prescriptions

The new Prescription Drive-Thru Pick-up will operate similarly as the curbside pharmacy pick-up.

Recommended Content:

Research and Innovation | Combat Support | Public Health | Coronavirus | Pharmacy Operations Toolkit | TRICARE Pharmacy Program | Health Literacy Month 2020

Updated Guidance for Performing Temperature Checks at Military MTFs and DTFs

Publication
10/21/2020

This guidance is an update to Defense Health Agency Return to Full Operations Concept of Operations, V5.0 (June 12, 2020) as it pertains to temperature checks in MTFs and DTFs. Based on recommendations from the Centers for Disease Control (CDC), previous guidance directed MTFs to take the temperature of all individuals entering the facility. Effective immediately, temperature checks are not required; however, screening of individuals entering MTFs and DTFs and healthcare personnel on duty in the MTF or DTF is to continue.

Recommended Content:

Coronavirus

Fort Irwin DENTAC strives to reach readiness perfection

Article
10/21/2020
Image of patient getting a dental exam

To accommodate an entire installation, the dental clinic extended its hours.

Recommended Content:

Public Health | Coronavirus | Combat Support | Dental Care

Specialized robots used to disinfect NH TwentyninePalms

Article
10/21/2020
Hospital personnel standing with a cleaning robot

The robotic units are designed to complement manual cleaning.

Recommended Content:

Public Health | Coronavirus
<< < ... 11 12 13 14 15  ... > >> 
Showing results 151 - 165 Page 11 of 31

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.